Related Experiment Video
Updated: Feb 20, 2026

04:06
Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line
Published on: September 13, 2024
3.5K
Occipital shuntalgia: Rethinking post-shunt occipital headache etiology and care
Shachar Zion Shemesh1,2, Noa Rennert1,2, Zeev Feldman1,2
1Department of Neurosurgery, Sheba Medical Center, Ramat Gan, Israel.
Acta Neurochirurgica
|February 18, 2026
Summary
Headache after ventriculoperitoneal (VP) shunting may stem from occipital neuralgia, not just shunt issues. Nerve-targeted treatments offer better relief for this specific headache type than shunt revisions.
Area of Science:
- Neurosurgery
- Neurology
- Pain Medicine
Background:
- Headaches post-ventriculoperitoneal (VP) shunting are often attributed to CSF over-drainage or shunt malfunction.
- A distinct cause, occipital neuralgia, may arise from shunt hardware irritating occipital nerves.
Purpose of the Study:
- To investigate occipital neuralgia as a cause of headache after VP shunting in adults.
- To compare the effectiveness of nerve-targeted treatments versus shunt revisions for this condition.
Main Methods:
- Retrospective review of 2,223 adults undergoing VP shunt placement.
- Classification of post-shunt headaches based on occipital neuralgia criteria (occipital pain, tenderness, nerve block response).
- Comparison of clinical features, management, and outcomes between occipital neuralgia and other headache groups.
Main Results:
- 1.44% of patients developed new, persistent headaches; 1.08% met criteria for occipital neuralgia.
- Occipital neuralgia patients presented with occipital pain, scalp tenderness, and normal neuroimaging for pressure issues.
- Nerve-targeted therapies provided significant relief, while shunt interventions were less effective.
Conclusions:
- Occipital neuralgia is an under-recognized cause of headache following VP shunting.
- Early identification of the neuropathic phenotype and nerve-targeted therapy are crucial for effective management.
- Further prospective studies are needed to validate diagnostic criteria and treatment pathways.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Glaucoma: Overview
1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K

